Previously we have discussed neuropathy in the context of diabetic neuropathy, back-related neuropathies and the like. However, this week we are going to discuss an autoimmune neuropathy called ...

Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting about 1 in 100,000 people, according to the U.S. Centers for Disease Control and Prevention. While GBS is more common in men and ...

A new Guillain-Barré syndrome mimic that appeared to be triggered by mild infection emerged in children with biallelic RCC1 variants, a case series showed. One of the first cases was seen in a ...

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...

This week, we are going to continue down the road of autoimmune peripheral nerve conditions to discuss two that we have touched on in the past—Guillain-Barré Syndrome and CIDP (chronic inflammatory ...

Medically reviewed by Oluseun Olufade, MD Key Takeaways Plantar fasciitis is one of the most common causes of foot pain, especially in people with flat feet or high arches.Metatarsalgia causes pain in ...

The Johnson & Johnson COVID-19 vaccine will now include a U.S. Food and Drug Administration warning because of the chance of an increase in the risk for a rare neurological disorder. The disorder, ...

Not all Guillain-Barré cases are associated with infection, and studies have suggested a link between the rare disorder and certain cancers, including lymphomas. Certain cancers, such as lymphomas, ...

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus (RSV) vaccine. Two people in their 60s ...

LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor event on Guillain-Barré syndrome (GBS) on Monday, ...

The Johnson & Johnson COVID-19 vaccine will now include a U.S. Food and Drug Administration warning because of the chance of an increase in the risk for a rare neurological disorder. The disorder, ...